Total Payments
$25,014
2024 Payments
$1,925
Companies
6
Transactions
25
Payment Breakdown by Category
Consulting$24,850 (99.3%)
Food & Beverage$157.50 (0.6%)
Education$6.78 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,850 | 15 | 99.3% |
| Food and Beverage | $157.50 | 6 | 0.6% |
| Education | $6.78 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $24,873 | 16 | $0 (2024) |
| Mirum Pharmaceuticals, Inc. | $34.64 | 1 | $0 (2023) |
| Travere Therapeutics, Inc. | $32.89 | 5 | $0 (2020) |
| Retrophin, Inc. | $30.00 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $29.95 | 1 | $0 (2017) |
| Beckman Coulter, Inc. | $13.68 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,925 | 2 | PFIZER INC. ($1,925) |
| 2023 | $2,835 | 3 | PFIZER INC. ($2,800) |
| 2022 | $4,200 | 2 | PFIZER INC. ($4,200) |
| 2021 | $4,288 | 3 | PFIZER INC. ($4,288) |
| 2020 | $5,983 | 8 | PFIZER INC. ($5,950) |
| 2019 | $5,731 | 5 | PFIZER INC. ($5,688) |
| 2017 | $53.07 | 2 | Alexion Pharmaceuticals, Inc. ($29.95) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/11/2024 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/28/2023 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/08/2023 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/19/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $34.64 | General |
| Category: Alagille syndrome | ||||||
| 11/21/2022 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/16/2022 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2021 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/28/2021 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/17/2021 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,837.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/01/2020 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/05/2020 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/11/2020 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Hepatology | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $2.56 | General |
| Category: Hepatology | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $2.56 | General |
| Category: Hepatology | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 11/04/2019 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/24/2019 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,012.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/01/2019 | Beckman Coulter, Inc. | AU5800 SERIES (Device) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CHEMISTRY | ||||||
| 04/22/2019 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/18/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Kidney Stones | ||||||
| 06/23/2017 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: INFLAMMATION | ||||||
| 05/03/2017 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Immunology | ||||||
About Dr. Steven Schwarz, MD
Dr. Steven Schwarz, MD is a Pediatrics healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801858345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Schwarz, MD has received a total of $25,014 in payments from pharmaceutical and medical device companies, with $1,925 received in 2024. These payments were reported across 25 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($24,850).
Ad
Practice Information
- Specialty Pediatrics
- Location Brooklyn, NY
- Active Since 04/03/2006
- Last Updated 05/16/2013
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801858345
Products in Payments
- XELJANZ (Drug) $24,850
- Livmarli (Drug) $34.64
- (820) Cholbam (Drug) $32.89
- (815) Thiola (Drug) $30.00
- Kanuma (Drug) $29.95
- INFLECTRA (Biological) $23.12
- AU5800 SERIES (Device) $13.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Brooklyn
Warren Seigel
Pediatrics — Payments: $147,615
Pediatrics $147,615
Dr. Patrick Schnell, M.d, M.D
Pediatrics — Payments: $135,686
Pediatrics $135,686
Dr. Howard Levine, M.d, M.D
Pediatrics — Payments: $134,944
Pediatrics $134,944
Dr. Jeannette Jakus, Md, MD
Pediatrics — Payments: $46,151
Pediatrics $46,151
Dr. Sherry Sakowitz, M.d, M.D
Pediatrics — Payments: $26,796
Pediatrics $26,796
Mr. Han Zhang, M.d, M.D
Pediatrics — Payments: $14,639
Pediatrics $14,639